LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Rani Therapeutics Holdings, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERRANI
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / RANI COVERAGE

What’s moving Rani Therapeutics Holdings, Inc. now

Current reporting with the operating signal separated from the noise.

01
TradingView

Enterprise value to revenue forward of Rani Therapeutics Holdings, Inc. – NASDAQ:RANI

Investors are testing whether Rani Therapeutics Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest RANI filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-30 · Period 2026-06-24SEC ↗8-KMaterial company eventFiled 2026-05-29 · Period 2026-05-28SEC ↗8-KMaterial company eventFiled 2026-05-27 · Period 2026-05-26SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-16 · Period 2026-05-28SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Rani Therapeutics Holdings, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.